Become a Member

Topic Archives: MDMA

Comments

  • I believe it is only a matter of time before the good companies in psychedelics take off.There is too much evidence the...

  • Nice even-handed summary. Google scholar has some reviews on efficacy of the treatments, most of which look "promising" ...

  • Mydecine (MYCOF). Valuation: $94M. Pipeline: Phase 2A clinical on PTSD and smoking cessation. Molecule: pure psilocybin ...

  • Ei.ventures. Valuation: Pre-IPO, in the process of raising capital $50M. Pipeline: None. Molecule: Natural psilocybin ex...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info